CRP and COVID-19: Interestingly, the seeming promotion of insulin resistance by high levels of C-reactive protein, which could not be sustained when TyG was the surrogate marker, in the entire sample, irrespective of COVID-19 status, was rather sustained only in the sub-group analysis in participants with past COVID-19 status.